法国Novasep
Novasep 开发、销售和应用创新技术，为生命科学行业提供安全且具成本效益的活性分子生产工艺。 Novasep 提供的全球制造解决方案包括工艺开发服务；净化设备和系统；合约制造服务及复杂的活性分子。 Novasep 的产品应用于医药、生物制药、食品、功能性成份及生物行业市场。
 本公司在法国、德国和巴哈马设有六间受 FDA 检查的制造厂，在比利时设有两间生物医药生产地点，在美国、中国和法国设有设备制造设施，在日本设有一间办事处。本公司拥有大约1,300名员工，2009年的年度收入为3亿欧罗。目前有2,000多种 Novasep 设计和生产的系统在全球各地净化活性分子。本公司拥有超过200项技术和工艺专利。

Novasep brings innovative solutions to complex challenges within the life science industries for the production of synthetic molecules and biomolecules.

In order to fulfill our customers’ ingredient needs, we develop and use a broad portfolio of technologies to support our unique business model:

we develop manufacturing solutions,
we provide custom manufacturing services (outsourcing solutions),
we sell purification processes (in-sourcing solutions).
Our offering helps our customers to enhance product quality, reduce production costs and shorten time-to-market.

We operate through two complementary business divisions, Novasep Process and Novasep Synthesis.

Novasep Synthesis uses a large range of chemical synthesis and purification technologies to develop and produce high value-adding active ingredients and advanced intermediates for the pharmaceutical, crop science and other fine chemical industries.

Novasep Process develops and supplies innovative purification processes, equipment and systems for the pharmaceutical, biopharmaceutical and industrial biotechnology industries and provides contract manufacturing services for biopharmaceuticals.